Dus good Tuesday Morning i spoke with aws ceo exclusively last night covering a wide range of topics. Youll hear about all hour including Data Warehousing and the emergence of snowflake in that space which by the way runs on aws heres what jasy said about whether there is room enough for snowflake and aws sorry, snowflake competitor from aws red shift in the market. I think its unquestionable that theres room for both snowflake and red shift to be very successful and grow to be very, you know, a lot larger than both of them are today. We launched redshift back in 2012 and it was the first Data Warehouse built for the cloud and continues to be the largest Data Warehouse in the cloud. And, you know, snowflake built a Data Warehousing offering as well that is also strong offering and largely runs on top of aws we work just as hard for snowflake in trying to make it easy for people to use redshift. From our perspective, if customers want to run on snowflake for their Data Warehouse on top
Authorizati authorization as soon as today and well have analysis of the upcoming Holiday Season. And later on, a 170 mile trip for one lonely owl that you could call a miracle on 49th street you are watching worldwiworldwe exchange right here on cnbc fly free free bird, yeah happy friday, im democrat ni dominic chew u in for Brian Sullivan as you can see, the dow jones currently implied lower by 77 points fr so slight outperformance from the nasdaq here, implied open by six points to the up side. The major averages all snapping two day losing streaks yesterday. The dow on pace for its third positive week in a row, but just barely rest nearly flat on the week take a look around the world, a mixed session overnight any asia as you see, the nikkei down when 0. 5 and similar gains in the chinese markets. Meanwhile trading just Getting Started in europe with about half percent gains for the major forces there, including the german dax, ftse 100 and cac again, green across the screen in eur
Overspeed. The communist party wants greater sustainability. The ecb hints that a more stimulus is coming as governments impose new lockdowns. Seize until the crisis dies down. Breaking news out of south korea, we are getting the september numbers for Industrial Production, a rebound of 5. 4 . This is a rebound from a can fraction in the previous period. We are seeing revisions upwards for the previous month of august. This is a huge beat of estimates. Growth, on year number, a jump of 8 , really rebounding after six months of contraction for Industrial Production. That werising given have seen export numbers rising for the first time in seven months. We have seen more positive sentiment on external demand. Now we have Industrial Production numbers in south korea beating estimates. Just had the markets open in australia. At amp, one of the first stocks trading, higher by more than 20 . This is after they confirmed they have received a conditional proposal from u. S. Based areas, not en
Strong data on housing and jobs along with big beat for chicago pmi. Late breaking headlines regarding modernas vaccine. Off session highs but off the lows as we speak still wog up on the show. Coming up San Francisco fed president mary daly to talk about economic recovery, stimulus and jobs picture in america. Plus we will get a read on the consumer when we talk to the ceo of General Mills his first interview since reporting earnings last week. Cocacola entering Hard Seltzer Market with help from molson coors well talk to the ceo of molson coors exclusively about this partnership and more lets get to the big stories 59 minutes of trade. Mike santoli tracking Market Action as stocks look to close out september with a bang. Meg tirrell with headlines around moderna and leslie with the latest on palantirs review. The market, whats driving it . Sara, a lot of things blowing around in the market, quarter end, reaction to the debate, pretty good economic numbers but also in the context of a
Else, stimulus optimism. Pelosi and mnuchin are set to speak again. Airline stocks are up. Plus the race for a cure and treatment for the coronavirus. Shares of regeneron and eli lilly are rallying, both asking the fda for emergency use approval for their antibody therapies. And speaking of surging, look at shares of ibm this morning, moving up on plans to spin off its it infrastructure unit Arvind Krishna and Ginni Rometty will both join us first to discuss this historic move for the company. Carl we are awash in headlines from the president after this 55minute interview. But buried in there are discussions about the progress of stimulus talks and emergency approval for the likes of lilly and regeneron. Look, i think that there is a narrative that were going to start hearing and it was the president s narrative, he voiced it, i know if youre george ancopolous, you dont want to hear it is a cure. You want to hear it is something that is part of a cocktail of things that you need to be